EXELIXIS INC's ticker is EXEL and the CUSIP is 30161Q104. A total of 372 filers reported holding EXELIXIS INC in Q2 2023. The put-call ratio across all filers is 0.08 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $3,569,963 | +63.1% | 163,385 | +42.7% | 0.00% | +50.0% |
| Q2 2023 | $2,188,381 | -96.8% | 114,515 | -96.4% | 0.00% | -97.0% |
| Q2 2018 | $68,740,000 | -40.7% | 3,194,242 | -38.9% | 0.07% | -41.7% |
| Q1 2018 | $115,829,000 | -9.9% | 5,229,282 | +23.7% | 0.12% | -9.4% |
| Q4 2017 | $128,554,000 | +73.3% | 4,228,761 | +38.1% | 0.13% | +67.1% |
| Q3 2017 | $74,168,000 | +4.8% | 3,061,003 | +6.5% | 0.08% | +1.3% |
| Q2 2017 | $70,771,000 | +25.1% | 2,873,349 | +10.1% | 0.08% | +23.0% |
| Q1 2017 | $56,563,000 | +35.2% | 2,610,214 | -7.0% | 0.06% | +29.8% |
| Q4 2016 | $41,827,000 | +554.1% | 2,805,314 | +461.1% | 0.05% | +571.4% |
| Q3 2016 | $6,395,000 | -52.7% | 500,000 | -77.3% | 0.01% | -46.2% |
| Q4 2013 | $13,520,000 | -11.3% | 2,205,478 | -15.8% | 0.01% | -18.8% |
| Q3 2013 | $15,240,000 | – | 2,618,530 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Meditor Group Ltd | 15,001,073 | $199,507,000 | 56.91% |
| Sargent Investment Group, LLC | 1,032,560 | $18,193,000 | 3.40% |
| Bellevue Group AG | 3,930,700 | $69,259,000 | 1.10% |
| CAPITAL MANAGEMENT CORP /VA | 231,880 | $4,086,000 | 1.04% |
| Orbimed Advisors | 3,753,700 | $66,140,000 | 0.94% |
| TEALWOOD ASSET MANAGEMENT INC | 121,848 | $2,147,000 | 0.90% |
| FARALLON CAPITAL MANAGEMENT LLC | 7,500,000 | $132,150,000 | 0.89% |
| Chicago Capital, LLC | 806,113 | $14,204,000 | 0.87% |
| Penn Capital Management Company, LLC | 456,587 | $8,045,000 | 0.84% |
| AJO, LP | 7,636,882 | $134,561,000 | 0.80% |